Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
暂无分享,去创建一个
J. Viikari | O. Raitakari | C. Magnussen | M. Juonala | D. Cuthbertson | Tomi T. Laitinen | N. Hutri-Kähönen | E. Jokinen | M. Sabin | P. Tossavainen | E. Brown | J. Koskinen
[1] G. Perseghin,et al. High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes , 2020, Diabetes Care.
[2] G. Valerio,et al. Uric acid, impaired fasting glucose and impaired glucose tolerance in youth with overweight and obesity. , 2020, NMCD. Nutrition Metabolism and Cardiovascular Diseases.
[3] G. Valerio,et al. High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity , 2019, Journal of Endocrinological Investigation.
[4] T. Tuomainen,et al. Association of fatty liver index with risk of incident type 2 diabetes by metabolic syndrome status in an Eastern Finland male cohort: a prospective study , 2019, BMJ Open.
[5] S. Shin,et al. Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus , 2019, Gut and liver.
[6] D. Mauricio,et al. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study , 2018, PloS one.
[7] E. Bonora,et al. Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis , 2018, Diabetes Care.
[8] R. Hultcrantz,et al. Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[9] K. Cusi,et al. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease , 2017, Hepatology.
[10] K. Sung,et al. Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study , 2016, Medicine.
[11] L. Henry,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.
[12] Hong-Kyu Kim,et al. Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity , 2016, Obesity.
[13] T. Lehtimäki,et al. Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study , 2015, Annals of medicine.
[14] Eric J. Brunner,et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study , 2014, European heart journal.
[15] Jimmy D Bell,et al. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. , 2014, European journal of endocrinology.
[16] S. Kunutsor,et al. Alanine Aminotransferase and Risk of the Metabolic Syndrome: A Linear Dose-Response Relationship , 2014, PloS one.
[17] F. Hu,et al. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. , 2013, The lancet. Diabetes & endocrinology.
[18] J. Walley,et al. Liver aminotransferases and risk of incident type 2 diabetes: a systematic review and meta-analysis. , 2013, American journal of epidemiology.
[19] Jonathan C. Cohen,et al. Human Fatty Liver Disease: Old Questions and New Insights , 2011, Science.
[20] R. Stolk,et al. Ultrasonography to Quantify Hepatic Fat Content: Validation by 1H Magnetic Resonance Spectroscopy , 2009, Obesity.
[21] M. Schulze,et al. Findings from the European Prospective Investigation Into Cancer and Nutrition (EPIC)-Potsdam Study , 2008 .
[22] A. Hakkarainen,et al. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects. , 2008 .
[23] Anna Castiglione,et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population , 2006, BMC gastroenterology.
[24] S. Grundy,et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.
[25] P. Macfarlane,et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. , 2004, Diabetes.
[26] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[27] T. Laitinen,et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. , 2003, JAMA.
[28] A. Zanella,et al. Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels , 2002, Annals of Internal Medicine.
[29] C. Bogardus,et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. , 2002, Diabetes.
[30] G. Marchesini,et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.
[31] G. Colditz,et al. Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women , 1995, Annals of Internal Medicine.
[32] G A Colditz,et al. Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men , 1994, Diabetes Care.